News Roundup / Russian Pharma: April 2020
Below is a selection of top stories in Russian pharma from recent months, ranging from proposed changes in…
Top Stories
Coronavirus / How US Generics Firms are Responding to COVID-19 Supply Chain Risks
AAM Interim President Jeff Francer outlines the vital role that biosimilar and generics firms will play in filling supply chain gaps during the ongoing coronavirus pandemic. Like the rest…
Hot Topics / Mexican Pharma
Earlier in 2020, PharmaBoardroom sat down with several key stakeholders in the Mexican healthcare and life sciences…
CEE / Romania's Vaccination Crisis: Small Steps Forward
Quite unfortunately, Romania has some of the highest infant mortality and maternal mortality rates in Europe, and…
Company Spotlight / STADA Czech Republic
As one of the few pharma companies in the Czech Republic to offer products across the whole healthcare spectrum,…
Legal & Regulatory / Pricing and Reimbursement in China
An intro to the regulatory, pricing and reimbursement scenario for pharmaceuticals in China. Prepared in…
Coronavirus / 5 Questions to 5 Leading Pharma Execs on the COVID-19 Pandemic
The CEOs and top executives, David Ricks, chairman and CEO, Eli Lilly & Co and IFPMA president, Severin Schwan,…
In Conversation
Christos Andriopoulos – Managing Director, Merck Belgium & Luxembourg
Christos Andriopoulos, managing director of Merck, speaks about his experience transitioning from global operations to leading a country subsidiary. Andriopoulos goes on to explain the company’s unique positioning as an innovative specialty pharma player balancing a core business with an increasing focus on specialty areas. He also offers insights on the changing Belgian landscape in the context of political uncertainty…
InFocus Market Insight on Artificial Intelligence
Demystifying AI
The AI in Life Sciences Market was valued at USD 902.1 million in 2019 by Mordor Intelligence and is projected to…
De-risking Drug Discovery with Artifical Intelligence
On the supply side, AI appears to herald the prospect of de-risking the drug discovery process and doing away with…
Rethinking Healthcare Provision with AI
As data and information proliferate at an exponential pace, many industries have turned to artificial intelligence…
Challenges to AI in Life Sciences
With so many wild predictions being bandied around about AI’s potential to radically transform healthcare for the…
Focus on Coronavirus
Indian Pharma Supply Chain Hit by Coronavirus Outbreak
The ongoing coronavirus outbreak and the subsequent shutdown of factories in…
5 Questions to 5 Leading Pharma Execs on the COVID-19…
The CEOs and top executives, David Ricks, chairman and CEO, Eli Lilly & Co…
How US Generics Firms are Responding to COVID-19 Supply…
AAM Interim President Jeff Francer outlines the vital role that biosimilar and…
Coronavirus Poised to Undermine China’s Healthcare Miracle
Eurasia Group's Aditya Bhattacharji examines the unfolding coronavirus outbreak,…
Read more: Coronavirus >>
Focus on CEE
New Hungary Pharma Report 2020 Out Now
In line with its status as one of Europe’s most dynamic economies, Hungary is…
Pharma Faces: Jorge Levinson, Bayer Romania
Appointed in August 2019 to head up Bayer Romania and Moldova’s…
Pharma Faces: Jiří Žák, Chairman of FARMAK, Czech…
In 1996 Jiří Žák, chairman & current CEO of FARMAK, borrowed half a…
Romania’s Emergency Healthcare Ordinance: Papering Over…
State hospitals in Bucharest are increasingly overloaded with patients due to a…
Read more: CEE >>
Focus on Mexico
Mexican Pharma Roundup: February 2020
Below is a selection of top recent news from Mexican pharma and healthcare,…
The Ideal Pharma Country Manager: Mexico (Korn Ferry)
What traits, competencies and drivers do you need to be a successful pharma…
Hot Topics in Mexican Pharma
Earlier in 2020, PharmaBoardroom sat down with several key stakeholders in the…
How do we Encourage Patients to Continue Taking their…
David Peña Castillo, president and founder of the Mexican Federation of Rare…
Read more: Mexico >>
Focus on MENA
The UAE: Becoming a Global Pharma Management Hub
From Turkey to Tajikistan, Bangladesh to Bahrain, and Russia to Rwanda,…
UAE to Boost Health Research Capabilities as Part of 50-Year…
The United Arab Emirates’ Cabinet, the de facto executive branch of the…
Saudi Arabia’s Bold Ambition to Become a Regional Pharma…
Saudi Arabia is aiming to become a more attractive investment destination for…
New IQVIA Study Sparks Controversy in Moroccan Pharma
Ensuring the country’s “sanitary sovereignty” has long been a key policy…
Read more: MENA >>
Focus on USA
Roche’s Coronavirus Test Gets FDA Emergency Use…
Over the past few years, innovative Swiss giant Roche has combined its position…
Indian Pharma Supply Chain Hit by Coronavirus Outbreak
The ongoing coronavirus outbreak and the subsequent shutdown of factories in…
Indian Generics in the USA: Destined for More Success?
A recent IQVIA report highlights the increasing importance of Indian firms to…
US FDA New Drug Approvals 2019 Snapshot
Annual numbers of new molecular entities (NMEs) and biologics license…
Read more: USA >>
Focus on Belgium
European Cancer Forum 2020: Belgian MoH Maggie De Block…
The second edition of the European Cancer Forum was held in Brussels, Belgium on…
Belgian Manufacturing’s Continuing Appeal for Global…
Over the past few decades, pharma multinationals have been increasingly drawn to…
CEO Profile: Jean-Christophe Tellier, UCB
Jean-Christophe Tellier became UCB’s CEO on January 1, 2015 only a few years…
Top 20 Pharma Companies in Belgium Ranking
The top 20 pharma companies in Belgium ranked by revenue for the financial year…
Read more: Belgium >>
Focus on China
Hot Topics in Chinese Biotech
PharmaBoardroom sat down with more than 25 biotech CEOs in China in 2019. We…
Chinese Biotechs Flock to IPO in Hong Kong
2019 was a bumper year for biotech companies listing on the Hong Kong Exchange…
Coronavirus Poised to Undermine China’s Healthcare Miracle
Eurasia Group's Aditya Bhattacharji examines the unfolding coronavirus outbreak,…
Indian Pharma Supply Chain Hit by Coronavirus Outbreak
The ongoing coronavirus outbreak and the subsequent shutdown of factories in…